Latest Asx Suspension News

OZZ Resources has entered a binding option agreement with Scorpion Minerals to sell its Maguires Reward project, securing an initial $100,000 fee and potential $2.5 million consideration pending shareholder approval. Exploration activity remained subdued across its portfolio during the December quarter.

Alice Queen Limited (AQX) has been suspended from ASX quotation due to its failure to adequately respond to regulatory queries, raising questions about its compliance status and future trading prospects.

ChemX Materials Limited has completed its Deed of Company Arrangement and appointed a new board, yet remains suspended from ASX trading while relying on director-related funding. The company is focused on stabilisation and exploring future opportunities.

Next Science Limited’s shares have been suspended from ASX trading due to insufficient ongoing operations following the disposal of its main business. The suspension raises questions about the company’s future direction and compliance with listing rules.

NT Minerals Limited has been suspended from ASX trading due to failure to meet operational requirements, raising questions about its future viability.

NT Minerals Limited faces suspension from ASX trading starting January 2026 due to insufficient operational activity, though it remains listed and committed to future exploration.

OZZ Resources has entered a binding option agreement with Scorpion Minerals, offering an exclusive chance to acquire its key tenements for $2.6 million plus a gold production royalty. The deal awaits shareholder approval and hinges on several regulatory and operational conditions.

DGL Group Limited has secured an extension of its syndicated debt facility to March 2027 and received a waiver protecting it from default amid its ASX suspension. The company anticipates its securities will be reinstated on the ASX by early 2026 following a half-year audit.

Star Minerals has secured court orders confirming the legitimacy of its auditor changes and share issuance notices, resolving prior compliance issues and lifting its ASX trading suspension.

Epsilon Healthcare reported a 19% revenue increase to $3.4 million for the half year ended June 2025, driven by new client wins and its pharmacy segment launch. However, net losses widened 44% to $2.07 million, reflecting administration and financing costs during its recovery phase.

Resources & Energy Group Limited (REZ) has requested an immediate voluntary suspension of its securities on the ASX as it prepares to announce a capital raising. The suspension is expected to lift by the start of trading on 16 December 2025 or upon the announcement release.

Wellard Limited's shares have been suspended from trading on the ASX as the company moves toward official delisting, marking a significant shift for investors and the livestock export sector.